Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Settlements: FTC Gets Teva To Eschew 'No-Authorized Generic' Deals

Executive Summary

Global settlement resolves charges against Teva in three pending FTC antitrust suits and expands terms of 2015 consent decree.

Advertisement

Related Content

Legal News: Teva V. FDA, Pay-For-Delay, Citizen Petitions, User Fee Scheme
Launch Abbreviated: Teva Halts US Generic Sensipar Sales After Patent Deal With Amgen
FTC Wins $448M Ruling Against AbbVie For Sham Litigation Rather Than Pay-For-Delay Deal
Impax Defeats FTC Pay-For-Delay Complaint, Helped By Status As Sole Marketer Of Generic Opana ER
Pay-For-Delay Settlements Decline In Wake Of Supreme Court Ruling
FTC Focus On Pay-For-Delay Deals Continues; Endo Agrees To 10-Year Abstention
Patent Settlements Blocking Authorized Generics May Get Supreme Court Review
FTC v. Endo: Does No-Authorized Generic Agreement Meet Supreme Court Pay-For-Delay Test?
Teva’s Pay-For-Delay Settlement Restricts Brand-Generic Deals
Pay-For-Delay Deals May Be Smaller After Supreme Court Okays FTC Suits

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel